CELEX: 62017TN0157
Language: en
Date: 2017-03-10 00:00:00
Title: Case T-157/17: Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)

24.4.2017   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 129/37
            
         Action brought on 10 March 2017 — Cristalfarma v EUIPO — Novartis (ILLUMINA)
   (Case T-157/17)
   (2017/C 129/57)
   Language in which the application was lodged: English
   
      Parties
   
   
      Applicant: Cristalfarma Srl (Milan, Italy) (represented by: R. Almaraz Palmero, lawyer)
   
      Defendant: European Union Intellectual Property Office (EUIPO)
   
      Other party to the proceedings before the Board of Appeal: Novartis AG (Basel, Switzerland)
   
      Details of the proceedings before EUIPO
   
   
      Applicant: Applicant
   
      Trade mark at issue: EU word mark ‘ILLUMINA’ — Application for registration No 11 934 239
   
      Procedure before EUIPO: Opposition proceedings
   
      Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 11 January 2017 in Case R 1187/2016-4
   
      Form of order sought
   
   The applicant claims that the Court should:
   
               —
            
            
               annul the contested decision;
            
         
               —
            
            
               order EUIPO and the other party, should it intervene, to pay the costs of proceedings, including those incurred before the Board of Appeal.
            
         
      Pleas in law
   
   
               —
            
            
               Infringement of Article 8(1)(b) of Regulation No 207/2009;
            
         
               —
            
            
               Infringement of Articles 75, 42(2) and 64(1) of Regulation No 207/2009.